The aim of this study is to evaluate the diagnostic efficacy of 3.0T MRI diffusion kurtosis imaging and quantitative dynamic contrast enhancement in benign and malignant breast lesions, and to explore the differential diagnosis ability of different pathological types and molecular subtype lesions. The results showed that 3.0T MRI diffusion kurtosis imaging and dynamic contrast-enhanced quantitative hemodynamic parameters are of great value in the differential diagnosis of benign and malignant breast lesions. The combination of both can significantly improve the diagnostic efficiency.
1. Partridge SC, McDonald ES. Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications[J]. Magnetic resonance imaging clinics of North America 2013;21:601-24. PMID: 23928248
2. Kato F, Kudo K, Yamashita H, et al. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI[J]. European journal of radiology 2016;85:96-102. PMID: 26724653
3. Bickelhaupt S, Laun FB, Tesdorff J, et al. Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs[J]. Radiology 2016;278:689-97. PMID: 26418516
4. Zaric O, Pinker K, Zbyn S, et al. Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors[J]. Radiology 2016;280:39-48. PMID: 27007803
5. Nogueira L, Brandao S, Matos E, et al. Application of the diffusion kurtosis model for the study of breast lesions[J]. European radiology 2014;24:1197-203. PMID: 24658871
6. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging[J]. Magnetic resonance in medicine 2005;53:1432-40. PMID: 15906300
7. Sun K, Chen X, Chai W, et al. Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors[J]. Radiology 2015;277:46-55. PMID: 25938679
8. Wu D, Li G, Zhang J, Chang S, Hu J, Dai Y. Characterization of breast tumors using diffusion kurtosis imaging (DKI) [J]. PloS one 2014;9:e113240. PMID: 25406010
9. Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer[J]. Journal of the National Cancer Institute 2009;101:736-50. PMID: 19436038
10. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J]. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24:2206-23. PMID: 23917950
11. An YY, Kim SH, Kang BJ. Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T[J]. PloS one 2017;12:e0174681. PMID: 28358833
12. Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis[J]. Acta radiologica (Stockholm, Sweden : 1987) 2016;57:651-60. PMID: 26275624